Epigenetic signature helps predict risk of metastatic thyroid cancer progression

Researchers from the Endocrine Tumors group at the Germans Trias i Pujol Research Institute (IGTP), in collaboration with five university hospitals, have conducted the first comprehensive study of DNA methylation patterns in metastatic differentiated thyroid cancer (DTC).

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup